GlaxoSmithKline PLC Director/PDMR Shareholding (4041Q)
18 Giugno 2020 - 01:25PM
UK Regulatory
TIDMGSK
RNS Number : 4041Q
GlaxoSmithKline PLC
18 June 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ==============================================================================================
a) Name Ms D Waterhouse
==== ======================================== ====================================================
b) Position/status CEO of ViiV Healthcare
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Following the final vesting on 15 June
transaction 2020 of an award made on 15 June 2017 under
the GlaxoSmithKline Deferred Investment
Award programme, Ms Waterhouse will receive
a cash payment of GBP75,564.47 less applicable
tax withholding in respect of 4,720.419
notional Ordinary Shares.
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
16.008 4,720.419
====================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ========================================================
e) Date of the transaction 2020-06-15
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFVLFFBQLLBBX
(END) Dow Jones Newswires
June 18, 2020 07:25 ET (11:25 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024